Levraut M[au] - Search Results

Year	Number of Results
2019	4
2020	3
2021	6
2022	7
2023	1

1

Immune thrombocytopenic purpura after COVID-19 infection.

Levraut M, Ottavi M, Lechtman S, Mondain V, Jeandel PY. Levraut M, et al. Int J Lab Hematol. 2021 Feb;43(1):e28-e30. doi: 10.1111/ijlh.13346. Epub 2020 Sep 20. Int J Lab Hematol. 2021. PMID: 32951347 Free PMC article. No abstract available.

2

Immunoglobulin G4-related hypertrophic pachymeningitis: A case-oriented review.

Levraut M, Cohen M, Bresch S, Giordana C, Burel-Vandenbos F, Mondot L, Sedat J, Fontaine D, Bourg V, Martis N, Lebrun-Frenay C. Levraut M, et al. Neurol Neuroimmunol Neuroinflamm. 2019 May 7;6(4):e568. doi: 10.1212/NXI.0000000000000568. eCollection 2019 Jul. Neurol Neuroimmunol Neuroinflamm. 2019. PMID: 31355304 Free PMC article. Review.

3

Dry Cough and Sicca Syndrome in a 51-Year-Old Congolese Man.

Courdurie A, Levraut M, Risso K, Boyer J, Martis N. Courdurie A, et al. Among authors: levraut m. Clin Infect Dis. 2021 Sep 7;73(5):933-934. doi: 10.1093/cid/ciaa1929. Clin Infect Dis. 2021. PMID: 34492700 No abstract available.

4

Refractory sarcoidosis-like systemic granulomatosis responding to ruxolitinib.

Levraut M, Martis N, Viau P, Suarez F, Queyrel V. Levraut M, et al. Ann Rheum Dis. 2019 Nov;78(11):1606-1607. doi: 10.1136/annrheumdis-2019-215387. Epub 2019 May 10. Ann Rheum Dis. 2019. PMID: 31076391 No abstract available.

5

A role for metformin in the treatment of Dupuytren disease?

Baeri A, Levraut M, Diazzi S, Camuzard O, Cegarra-Escolano M, Ploumellec MA, Balaguer T, Fassy J, Rezzonico R, Bellusci S, Mari B, Vassaux G. Baeri A, et al. Among authors: levraut m. Biomed Pharmacother. 2022 Jun;150:112930. doi: 10.1016/j.biopha.2022.112930. Epub 2022 Apr 12. Biomed Pharmacother. 2022. PMID: 35427821 Free article.

6

Cerebrospinal Fluid IL-17A Could Predict Acute Disease Severity in Non-NMDA-Receptor Autoimmune Encephalitis.

Levraut M, Bourg V, Capet N, Delourme A, Honnorat J, Thomas P, Lebrun-Frenay C. Levraut M, et al. Front Immunol. 2021 May 13;12:673021. doi: 10.3389/fimmu.2021.673021. eCollection 2021. Front Immunol. 2021. PMID: 34054854 Free PMC article.

7

Should we still only rely on EDSS to evaluate disability in multiple sclerosis patients? A study of inter and intra rater reliability.

Cohen M, Bresch S, Thommel Rocchi O, Morain E, Benoit J, Levraut M, Fakir S, Landes C, Lebrun-Frénay C. Cohen M, et al. Among authors: levraut m. Mult Scler Relat Disord. 2021 Sep;54:103144. doi: 10.1016/j.msard.2021.103144. Epub 2021 Jul 9. Mult Scler Relat Disord. 2021. PMID: 34274736

8

Marburg Multiple Sclerosis Variant: Complete Remission with Very Early Administration of Mitoxantrone-A Case Report.

Capet N, Levraut M, Delourme A, Thomel-Rocchi O, Bourg V, Cabre P, Vandenbos F, Mondot L, Lebrun-Frenay C. Capet N, et al. Among authors: levraut m. Neurol Ther. 2022 Mar;11(1):507-513. doi: 10.1007/s40120-021-00308-6. Epub 2021 Dec 2. Neurol Ther. 2022. PMID: 34859363 Free PMC article.

9

Glial Fibrillary Acidic Protein (GFAP) Astrocytopathy Presenting as Mild Encephalopathy with Reversible Splenium Lesion.

Héraud C, Capet N, Levraut M, Hattenberger R, Bourg V, Thomas P, Mondot L, Lebrun-Frenay C. Héraud C, et al. Among authors: levraut m. Neurol Ther. 2022 Mar;11(1):499-505. doi: 10.1007/s40120-021-00302-y. Epub 2021 Nov 29. Neurol Ther. 2022. PMID: 34843090 Free PMC article.

10

Comment on: Muscle fluorodeoxyglucose uptake assessed by positron emission tomography-computed tomography as a biomarker of inflammatory myopathies disease activity.

Martis N, Levraut M, Humbert O, Lidove O. Martis N, et al. Among authors: levraut m. Rheumatology (Oxford). 2019 Dec 1;58(12):2344-2345. doi: 10.1093/rheumatology/kez425. Rheumatology (Oxford). 2019. PMID: 31608941 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results